Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD19 antibody variable domain are respectively connected to the N terminus of the anti-CD59 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can recruit complement to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD59 Bispecific Antibody (scFv-IgG) (BSSG-043). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS